Alison Church Selected Research

GSK573719

1/2017	Umeclidinium/vilanterol as step-up therapy from tiotropium in patients with moderate COPD: a randomized, parallel-group, 12-week study.
4/2016	A randomised, open-label study of umeclidinium versus glycopyrronium in patients with COPD.
3/2016	Magnitude of umeclidinium/vilanterol lung function effect depends on monotherapy responses: Results from two randomised controlled trials.
1/2016	A randomized, parallel-group study to evaluate the efficacy of umeclidinium/vilanterol 62.5/25 μg on health-related quality of life in patients with COPD.
1/2016	A randomized, blinded study to evaluate the efficacy and safety of umeclidinium 62.5 μg compared with tiotropium 18 μg in patients with COPD.
1/2016	Genetic effects on treatment response of umeclidinium/vilanterol in chronic obstructive pulmonary disease.
1/2016	Efficacy and Safety of Umeclidinium Added to Fluticasone Propionate/Salmeterol in Patients with COPD: Results of Two Randomized, Double-Blind Studies.
1/2016	The effect of umeclidinium added to inhaled corticosteroid/long-acting β2-agonist in patients with symptomatic COPD: a randomised, double-blind, parallel-group study.
9/2015	Efficacy and safety of umeclidinium added to fluticasone furoate/vilanterol in chronic obstructive pulmonary disease: Results of two randomized studies.
8/2015	Umeclidinium/vilanterol versus fluticasone propionate/salmeterol in COPD: a randomised trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alison Church Research Topics

Disease

23	Chronic Obstructive Pulmonary Disease (COPD) 01/2017 - 01/2014
1	Asthma (Bronchial Asthma) 11/2014
1	Dyspnea (Shortness of Breath) 05/2014
1	Retinal Vasculitis 11/2003

Drug/Important Bio-Agent (IBA)

21	GSK573719IBA 01/2017 - 01/2014
14	vilanterolIBA 01/2017 - 05/2014
10	Muscarinic AntagonistsIBA 01/2016 - 01/2014
6	Bronchodilator Agents (Bronchodilators)IBA 01/2017 - 05/2014
4	Tiotropium Bromide (Spiriva)FDA Link 01/2017 - 06/2014
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2016 - 07/2015
3	Fluticasone-Salmeterol Drug Combination (Advair)FDA Link 01/2016 - 07/2015
2	Albuterol (Salbutamol)FDA LinkGeneric 04/2015 - 05/2014
1	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 04/2016
1	fluticasone furoate FDA Link 09/2015
1	Ipratropium (Ipratropium Bromide)FDA LinkGeneric 04/2015
1	BromidesIBA 01/2014
1	Chemokine CCL4IBA 11/2003
1	ChemokinesIBA 11/2003
1	Chemokine CCL3IBA 11/2003

Therapy/Procedure

7	Therapeutics 01/2017 - 05/2014
2	Nebulizers and Vaporizers (Inhaler) 01/2016 - 01/2014
1	Dry Powder Inhalers 01/2016